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Objective: The role of postmenopause on the pathogenesis of cartilage degeneration has been an open
question. We assessed cartilage degeneration in estrogen receptor (ER)a null mice and examined the role
of glucocorticoid receptor-interacting protein 1 (GRIP1) in the ERa-dependent transcription of a type II
collagen gene (col2a1) with special reference to a crosstalk with the transforming growth factor (TGF)-b
signaling pathway.
Methods: The vertebral cartilaginous endplate from female ERa null mice was subjected to histological
analyses. Col2a1 expression of primary chondrocytes (PCs) obtained from ERa null mice after
17b-estradiol (E2) and TGF-b1 stimulation was examined by reverse transcription polymerase chain
reaction (RT-PCR). Estrogen response element (ERE) or col2a1 promotereenhancer luciferase reporter
system was used to investigate the crosstalk among ERa, GRIP1, and MKK6. Col2a1 expression and
glycosaminoglycan (GAG) content were measured in ATDC5 cells treated with GRIP1 small interfering
RNA (siRNA).
Results: ERa deﬁciency clearly accelerated impairment of the vertebral cartilaginous endplate. E2 and
TGF-b1 stimulation increased col2a1 expression in PC from wild-type mice, but not that from ERa null
mice. The same stimulation increased the col2a1 promotereenhancer reporter activity, and the elevated
activity was decreased by dominant-negative ERa and p38 mitogen-activated protein kinase (MAPK)
inhibitor. GRIP1 increased the E2-dependent ERE activation in the presence of ERa and constitutive-
active MKK6. GRIP1 siRNA repressed col2a1 expression and GAG production in ATDC5 cells.
Conclusions: Crosstalks between ERa/GRIP1 and TGF-b/MKK6/p38 MAPK pathway have protective roles
on cartilage metabolism via regulating the extracellular matrices expression. The ﬁnding may lead to the
development of a novel therapeutic approach for cartilage degeneration.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Endogenous estrogen depletion is believed to contribute to
several health problems through women’s life. Several epidemio-
logical studies suggested that the postmenopausal state is involved
with the development of some gender-speciﬁc diseases such as
osteoarthritis and lumbar degenerative spondylolisthesis1,2. These
diseases are attributed to cartilage damage in the knee joint, the
vertebral endplate, and the intervertebral disc of the lumbar spine.ironari Takaishi, Department
niversity, 35 Shinanomachi,
2; Fax: 81-3-3353-6597.
shi).
s Research Society International. PThe epidemiological gap of the incidence of diseases between
females and males continues to increase with aging3. Although the
presence of estrogen receptors (ERs) in chondrocytes raises
a possibility that cartilaginous tissues are estrogen-sensitive, the
precise mechanism of cartilage homeostasis by estrogen is not fully
understood4.
Estrogen, especially 17b-estradiol (E2) has versatile effects on
physiology of chondrocytes from proliferation to differentiation5,6.
In fact, aged ERa null mice show an early closure of the epiphyseal
growth plate in long bones7. ERa exerts its function by binding to
the estrogen response elements (EREs) in the promoter region of
the target genes, recruiting many cofactors to form a large multi-
subunit complex, which deﬁnes the transcription of the genes8.
Glucocorticoid receptor-interacting protein 1 (GRIP1) is one of theublished by Elsevier Ltd. All rights reserved.
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with nuclear receptors9. Interaction of GRIP1 with E2-bound ERa
recruits histone acetyl-transferase and cAMP response element-
binding (CREB) binding protein (CBP)/p300, and leads to form
a large coactivator complex. Through phosphorylation of the
coactivator complex, some of the signaling cascades are known to
promote target gene expressions. p38 mitogen-activated protein
kinase (MAPK), a member of MAPK signaling pathway, is reported
to stimulate the ERa-dependent ERE transcription by phosphory-
lation of S736 of GRIP1 in breast and endometrial carcinoma cells10.
A crosstalk between ERa and p38 MAPK enhances ERa-depen-
dent tumor growth inMCF-7 cells11. In ATDC5 cells, a transcriptional
crosstalk among Sma and mothers against decapentaplegic (MAD)-
related protein 2 (Smad2), extracellular signal-regulated kinase 1/2
(ERK1/2), and p38MAPK regulates aggrecan gene expression12. One
of the signal transduction modulators in the transforming growth
factor (TGF)-b signaling, p38 MAPK, plays an important role for
proliferation of chondrocytes13. TGF-b rapidly activates p38 MAPK
and its direct activator mitogen-activated protein kinase kinase
(MKK) 6 in its transcriptional activation in mouse mammary gland
cell14. However, it remains to be determined whether estrogen
affects MKK6-p38 MAPK pathways in chondrocytic cells.
Type II collagen is a major extracellular matrix component of the
articular cartilage and has crucial roles in cartilaginous homeostasis.
Transcription of col2a1 is mainly controlled by sex-determining
region Y (SRY)-type highmobility group box9 (Sox9)15,16. Sox9 binds
to the enhancer region of col2a1 gene, which is located in the ﬁrst
intron, and forms a large transcriptional complex with cofactors
such as CBP/p30017. The transcriptional complex is believed to bend
backward and make a contact with the general transcriptional
machinery, especially RNA polymerase at a translation initiation site
leading to chondrocyte-speciﬁc expression of col2a118. TGF-b1
controls the Sox9-mediated col2a1 transcription by Smad-depen-
dent19 and -independent pathways20. Both the TGF-b/Smad3 and
TGF-b/MKK6/p38 MAPK pathways result in the formation of Sox9-
containing transcriptional complex. In addition, Sox9 is a post-
transcriptional target of the p38 MAPK pathway in chondrocytes.
Indeed, p38 MAPK is involved in both superinduction of Sox9 by
cycloheximide and stabilization of Sox9 mRNA21.
Here,we veriﬁed a hypothesis that the postmenopausal estrogen
depletion accelerates cartilage degradation by examining the
phenotypes of ERa null mice. We present evidence that estrogen
increases col2a1 transcription through the TGFeMKK6 pathway in
primary chondrocytes (PCs) and chondrogenic ATDC5 cells.
Furthermore, we revealed the function of GRIP1 in ERa-dependent
col2a1 expression and glycosaminoglycan (GAG) production in
ATDC5 cells. The results obtained in this study manifest the role of
estrogen in the maintenance of cartilage homeostasis.Materials and methods
Plasmids
A DNA fragment containing 1 kb human col2a1 promoter or
a col2a1-4 48 bp enhancer andbasal promoter (164 to 37 bp)was
generated by PCRusing genomicDNA fromHeLa cells. The fragments
were cloned into pGL3-basic (Promega,Madison,WI). The constructs
were veriﬁed by DNA sequencing. Human ERa and dominant-
negative (DN) ERa plasmids were gifts from Dr. D.P. McDonnell22.
ERE-TATA-luc was from Dr. J. Yanagisawa23. MKK6CA was from
Dr. T. Sudo24. Sox9 and p300 were gifts from Dr. H. Asahara17. GRIP1
and GRIP1-DAD1 (full-length GRIP1 without amino acids
1057e1109) plasmids were from Dr. M. Stallcup25. Enhanced green
ﬂuorescent protein (EGFP)-GRIP1 was from Dr. G.L. Hager26.Histological stainings
Heterozygous ERa null mice in C57BL/6 background were
purchased from Taconic (Hudson, NY). The animals were kept
under pathogen-free conditions and cared for in accordance with
the Laboratory Animal Care and Use Committee of School of
Medicine Keio University. The dissected lumbar units of wild-type
(WT) and ERa null female mice were ﬁxed in 10% neutral buffered
formalin. The samples were decalciﬁed by 5% formic acid, parafﬁn-
embedded, and sectioned to 4 mm thickness. The decalciﬁed
sections were stained with alcian blue and type II collagen with
rabbit anti-mouse polyclonal antibody (Millipore, Billerica, MA) as
previously described27.
Cell culture and treatments
PCs of WT and ERa null mice were prepared from newborn and
E18.5 embryos in pregnant heterozygous ERa null mice as
described28. PCs were plated in 24-well dish at a density of 1105
cells in 0.5 ml of Dulbecco's modiﬁed Eagle's medium (DMEM)/F12
and 10% fetal bovine serum (FBS). Next day, the medium was
replaced by a fresh medium supplemented with 2% Charcoal/
Dextran treated FBS (HyClone, Waltham, MA), 107 M E2 and 10 ng/
ml TGF-b1. After 16 h, RNA was recovered from chondrocytes with
RNAiso (Takara Bio, Shiga, Japan) for reverse transcription poly-
merase chain reaction (RT-PCR).
RT-PCR
Total RNA was used for the ﬁrst strand cDNA synthesis with
SuperScript II (Invitrogen, Carlsbad, CA). Real-time RT-PCR ampli-
ﬁcation was carried out using a SYBR Premix Ex Taq (Takara Bio) in
a Light Cycler Quick System (Roche Diagnostics, Mannheim,
Germany). Relative mRNA expression levels were obtained by
normalization against 18S rRNA. The experiments were repeated at
least three times to conﬁrm the reproducibility. The primers for
real-time RT-PCR used were: mouse 18S rRNA 50-ATCAGATACCG
TCGTAGTTCC-30 and 50-TGCCCTTCCGTCAATTCC-30; mouse col2a1
50-ACTGGTAAGTGGGGCAAGAC-30 and 50-CCACACCAAATTCCTGT
TCA-30. RT-PCR was performed with TaKaRa Ex Taq (Takara Bio).
The primers used were: mouse b-actin 50-GGCCCAGAGCAAGAGA
GGTATCC-30 and 50-ACGCACGATTTCCCTCTCAGC-30; mouse col2a1
50-GCCAAGACCTGAAACTCTGC-30 and 50-GCCATAGCTGAAGTGGA
AGC-30; mouse GRIP1 50-CCCATGCAAGATCCAAACTT-30 and 50-AGG
CCTCAGAGTCAGGTTCA-30.
Immunoﬂuorescence
ATDC5 cells (5104 cells) were plated on a glass coverslip in
a 24-well plate and cultured in DMEM/F12 with 10% FBS. Thirty
minutes later, the cells were transfected with 800 ng of EGFP-GRIP1
using FuGENE HD (Roche Diagnostics). Next day, the cells were
cultured with serum-free DMEM/F12 for 24 h. Then, cells were
incubated with 107 M E2 in 2% Charcoal/Dextran treated FBS for
16 h. The cells were ﬁxed with 4% paraformaldehyde in phosphate
buffered saline (PBS), permeabilized with 0.5% NP-40 in PBS and
incubated with rabbit anti-rat ERa. Confocal images were obtained
by Olympus IX71 (Olympus Corp., Tokyo, Japan).
Luciferase reporter assay
ATDC5 cells were maintained in DMEM/F12 containing 5% FBS
and antibiotics. Cells were plated at 7500 cells in a 48-well plate and
transfected with a 50 ng luciferase reporter plasmid containing
ahuman col2a1promoter,whichharbors a 4 48 enhancer element,
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Fig. 1. Impaired development of cartilage in ERa null mice. (A) Alcian blue staining of
the knee joint of 15-month-old WT and ERa null mice. Scale bar, 250 mm. (B) Alcian
blue (upper panel) staining and type II collagen immunostaining (lower panel) of the
intervertebral disc of 15-month-old WT and ERa null mice. Scale bar, 500 mm. Boxed
areas in the disorganized endplate are displayed in higher magniﬁcation underneath.
Scale bar, 100 mm.
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consensus EREs TATA luciferase reporter with Lipofectamine 2000,
according to the protocol provided (Invitrogen). We also transfected
5-100 ngof a DNERa expression vector22. One day after transfection,
cells were incubated with 2% Charcoal/Dextran treated FBS for 4 h
and were stimulated by 107 M or 109 M E2 in the presence of
107 M ICI182780 (E2 antagonist) (Tocris, St. Louis, MO) or 105 M
SB202190 (p38MAPK inhibitor) (Calbiochem, La Jolla, CA). After 16 h,
cell lysates were recovered for luciferase assay. Luciferase activity
was measured with a Dual Luciferase Reporter Assay System
according to the manufacturer’s instruction (Promega). The results
shown were as relative luciferase activities (RLA), the ratio of the
ﬁreﬂy activities to the Renilla (pRL-TK, Promega) activities.For luciferase assays using ON-TARGET plus small interfering
RNA (siRNA) (Dharmacon, Lafayette, CO), we adopted a different
protocol. Twenty-four hours prior to transfection of the luciferase
reporters, ATDC5 cells were seeded at a density of 1104 cells per
well in a 48-well plate. Fifty nanograms of the luciferase reporter
vector per well was transfected in combination with 5 ng of pRL-
TK, using FuGENE HD (Roche Diagnostics). On the next day,
various expression vectors (50 ng/well) and non-targeting siRNA
or the ON-TARGET plus smart pool of mouse GRIP1 siRNA
(12 pmoles/well) were also transfected with FuGENE HD (for
expression vectors), or Lipofectamine RNAiMAX (Invitrogen; for
siRNAs).
DMB assay
ATDC5 cells were plated at a density of 1104 cells per well in
a 24-well plate and maintained in DMEM/F12 medium containing
5% of charcoal-ﬁltrated FBS and 109 M of E2. Next day, non-
targeting siRNA or GRIP1 siRNA (24 pmoles/well) was transfected
with Lipofectamine RNAiMAX in the presence of 109 M E2. The
transfection was repeated every 3 days. Culture media and cell
lysates were harvested for GAG measurements at 14 and 21 days
after plating. Cells were harvested with ice-cold saline solution
containing 0.2% of Triton X-100 (Wako, Osaka, Japan). Cell lysates
were centrifuged at 2103 g for 5 min, and the supernatant was
used for determination of DNA content and sulfated GAG, as
described previously29,30.
Statistical analysis
Statistical analysis was performed by Student’s t test. P values
less than 0.05 were considered signiﬁcant.
Results
Cartilaginous endplate impairment in ERa null mice
We compared the skeletal growth plate morphology of female
ERa null mice with that of age matched female WT mice. There
was no difference in the morphology of 4-month-old mice
between the two genotypes. As reported7, the 15-month-old ERa
null mice had a closure of the epiphyseal growth plate in the
proximal tibia, while WT mice showed no sign of the growth plate
closure [Fig. 1(A)]. We also found more prominent decrease in the
thickness of the vertebral cartilaginous endplate in 15-month-old
ERa null mice compared to WT. As shown in Fig. 1(B), the number
of alcian blue-positive chondrocytes decreased in the cartilaginous
endplate of 15-month-old ERa null mice. The disorganized carti-
lage was replaced by bony tissues. Immunostaining of type II
collagen revealed that the collagen-negative areas increased in the
vertebral cartilaginous endplate of the ERa null mice [Fig. 1(B)].
These results suggested that the inactivation of the ERa gene
caused impaired development of the mouse vertebral endplate
cartilage in vivo.
Regulation of col2a1 expression in mouse PCs
Because in vivo results described above indicated the possible
link between the signaling elicited by ERa and the col2a1 expres-
sion in chondrocytes, we examined the direct effect of E2 on the
col2a1 expression using mouse PCs by RT-PCR and quantitative
real-time RT-PCR. PCs precultured with 2% FBS were stimulated
with 109e107 M E2 for 16 h. E2 increased the col2a1 message at
all concentrations tested [Fig. 2(A)]. Real-time RT-PCR conﬁrmed
a signiﬁcant increase in col2a1message by E2 [Fig. 2(B)]. To conﬁrm
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Results were expressed as the ratio of the ﬁreﬂy activities to the Renilla activities.
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Fig. 2. Crosstalk between E2 and TGF-b1 signaling in col2a1 mRNA expression in PC.
(A) The effect of E2 on col2a1 mRNA in PCs. Mouse PCs were incubated with indicated
concentrations of E2 for 16 h and processed for RT-PCR. (B) The effect of E2 on col2a1
mRNA in PCs. Mouse PCs were incubated with indicated concentrations of E2 for 16 h
and processed for real-time RT-PCR. N¼ 3. *Signiﬁcantly different from control,
P< 0.05. (C) Crosstalk of E2 and TGF-b1 signal in col2a1 expression in PCs. WT (left)
and ERa null (right) PCs were treated with 107 M E2, 10 ng/ml TGF-b1 for 16 h and
processed for real-time RT-PCR. N¼ 3. *Signiﬁcantly different from control, P< 0.05.
M. Kato et al. / Osteoarthritis and Cartilage 18 (2010) 934e941 937the involvement of ERa in the E2-dependent col2a1 upregulation,
we determined the effect of E2 on col2a1 expressions using PCs
prepared from ERa null mice. Real-time RT-PCR revealed that the
E2-dependent increase in the col2a1 expression observed inWT PCs
disappeared in ERa null PCs [Fig. 2(C)]. Additionally, TGF-b1
stimulation further increased the E2-dependent col2a1 message inWT PCs. The results suggest that the upregulation of col2a1
expression by ERa-dependent E2 signaling is mediated via TGF-b1
signaling in mouse PCs.
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TGF-b/P38MAPK signaling
Because the histological ﬁndings of ERa null mice accorded with
the in vitro E2-dependent increase in col2a1 expression of the iso-
lated mouse PCs, we examined the mechanism of E2-dependent
col2a1 transcription using the luciferase reporter system in ATDC5
cells, a chondrogenic cell line. ATDC5 cells were transfected with
the col2a1 luciferase reporter, which harbors a human col2a1
promoter and a 4 48 bp enhancer [Fig. 3(A)]. E2 at 107 M
increased the reporter activity by fourfold. This increase was
completely blocked by 107 M ICI182780, an E2 antagonist. On the
other hand, TGF-b1 at 10 ng/ml also increased the col2a1 reporter
activity by ﬁvefold. The increase was cancelled by 105 M
SB202190, a p38 MAPK inhibitor. A combination of E2 and TGF-b1
increased the reporter activity by sixfold. Although the elevated
transcriptional activity was partially blocked by ICI182780,
SB202190 completely inhibited the activation of col2a1 reporter
activity. Importantly, SB202190 attenuated both the E2-dependent
and TGF-b1-dependent col2a1 reporter activity to the basal level.
The E2 and TGF-b1-induced activation of col2a1 transcription was
inhibited by DN ERa in a dose-dependent manner, suggesting that
E2-bound ERa participated in the p38 MAPK pathway to activate
the col2a1 transcription in ATDC5 cells [Fig. 3(B)]. The luciferase
reporter activity activated by cotransfection of Sox9, p300, and
MKK6CA (constitutive-active MKK6) was also responsive to the E2
stimulation [Fig. 3(C)]. The results accord with the notion that E2
upregulated the Sox9-mediated activation of col2a1 transcription,
which depends on the TGF-b1/p38 MAPK pathway. Future works
are clearly needed to deﬁne the exact mechanism of interaction
between the E2-mediated pathway and the TGF-b1/p38 MAPK
pathway in the Sox9-mediated activation of col2a1 transcription
before reaching this conclusion.GRIP1 as a coactivator of ERE-dependent transcription in
chondrocytes
To further dissect the mechanism of E2-mediated upregulation
of col2a1 transcription, we elucidated the roles of GRIP1 on the
ERE-speciﬁc gene regulation in chondrocytes. First, we investigated
the effect of GRIP1 on the interaction of ERa and MKK6 using ERE-
TATA-luc in ATDC5 cells. In the presence of E2, MKK6CA increased
the reporter activity by threefold and a combination of MKK6CA
and ERa increased the activity by sevenfold [Fig. 4(A)]. DN ERa
completely cancelled the MKK6CA-induced reporter activity,
probably indicating that the activation of luciferase activity by
MKK6 required the endogenous ERa. Interestingly, GRIP1 signiﬁ-
cantly enhanced the activity induced by MKK6CA and ERa in the
presence of E2. The GRIP1-induced increase in the ERE-luc activity
was abolished by the cotransfection of GRIP1 siRNA. The GRIP1-
dependent activation of the ERE reporter activity was also inhibited
by the cotransfection of GRIP1mutant, GRIP1-DAD1 in the presence
of E2 [Fig. 4(B)], underlining the speciﬁcity of GRIP1 in the estrogen-
dependent transcription activity in ATDC5 cells. Finally, we exam-
ined the role of GRIP1 in the col2a1 transcription using the col2a1
luciferase reporter with a 1 kb human col2a1 promoter (976 to 0)
without the enhancer element in ATDC5 cells [Fig. 4(C)]. Although
the reporter activity in the presence of E2 was higher than that in
the absence of E2, the increasewas not signiﬁcant. Cotransfection ofcol2a1 promoter-luc, ERa, MKK6CA, GRIP1, control siRNA, or GRIP1 siRNA as in (A).
*Signiﬁcantly different from RLA without E2 stimulation, N¼ 3. A schematic model of
col2a1 promoter-luc was shown in the upper panel. Results were expressed as the ratio
of the ﬁreﬂy activities to the Renilla activities.
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(A) Inhibition of col2a1 expression by GRIP1 siRNA. ATDC5 cells were transfected with
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M. Kato et al. / Osteoarthritis and Cartilage 18 (2010) 934e941 939GRIP1, MKK6CA and ERa conferred the signiﬁcant E2 response on
the reporter activity. The E2 responsiveness was cancelled by the
cotransfection of GRIP1 siRNA. These results supported the
contention that GRIP1 acted as a coactivator in the col2a1 tran-
scriptional machinery in ATDC5 cells and that 1 kb upstream
sequence of col2a1 gene contained the putative ERE motif.
We next conﬁrmed the effect of GRIP1 on the endogenous
extracellular matrix production by ATDC5 cells using GRIP1 siRNA.E2
GRIP1 GRIP1
ER α
ERE
ICI182780
ER α
Fig. 6. Scheme of E2-dependent regulation of col2a1 gene expression in chondrocytes. TGF-b
activates col2a1 transcription through MKK6/p38/Sox9 pathway18. ERa bound with E2 inter
addition, GRIP1-ERa multisubunit complex8 might interact with Sox9-p300 transcriptional c
study. A broken line indicates a putative pathway. Points of action of various antagonists uTransient transfection of GRIP1 siRNA substantially decreased the
GRIP1 expression in ATDC5 cells with concomitant decrease in the
col2a1message [Fig. 5(A)]. The effect of GRIP1 siRNAwas also tested
by the quantiﬁcation of GAG in the cell matrix and supernatant of
ATDC5 cells [Fig. 5(B)]. Transfection of GRIP1 siRNA signiﬁcantly
decreased the ratio of GAG/DNA at 21 days of culture, but not at
14 days. These results clearly showed that GRIP1 acted as a positive
regulator not only for the col2a1 transcription but also for the GAG
production in ATDC5 cells.
We examined if ERa and GRIP1 colocalize in the nucleus using
confocal microscopy. Nuclear localization of ERa detected by
indirect immunoﬂuorescence was compared with that of the
transiently expressed EGFP-GRIP1 in ATDC5 cells [Fig. 5(C)]. GRIP1
expression in ATDC5 cells showed various morphologies from
diffuse nucleoplasmic staining with the low intensity to discrete
intranuclear foci with high intensity as described in HeLa cells26.
ERa antibody produced numerous granular staining patterns. A few
of the ERa-positive granules overlapped with some of the GRIP1-
positive granules which showed the intermediate intensity. The
overlapped granules might represent the active transcriptional
complex that include both ERa and GRIP131.Discussion
The aim of the present study is to resolve the relationship
between estrogen and cartilage metabolism. It has been reported
that 6-month-old ERa null female mice show no sign of cartilage
damage in the knee joints32. Consistent with this, we could not
observe an impaired development of the cartilaginous endplate in
4-month-old ERanull femalemice (data not shown). In contrast, ERa
null female mice at 15-month-old showed an obvious impaired
developmentof the cartilaginous endplatewith a reducednumberof
chondrocytes [Fig. 1(B)]. Similar phenotypes were also observed in
ovariectomized rats at 3 and 7months after surgery (Supplementary
data). Because the depletion of estrogen and functional loss of ERa
exhibited the similar phenotypes, it is reasonable to speculate that
estrogen has a positive role on the homeostasis of the cartilaginous
vertebral endplate in the aged animals. Especially, the function of
ERa seemed to be critical for themaintenance of the cartilagematrix.
This notionwas supported by in vitro experimental results using the
ERa null PC [Fig. 2(C)] and the col2a1 reporter assay [Fig. 3(B)].
Here we showed that the E2 induced col2a1 expression is
mediated by ERa in PCs (Fig. 2). The E2-dependent activationTGF -β
I II
M KK6
p38
SB202190
Exon2
Sox9
p300
< Col2a1 >
binds to TGF-b type I receptor on plasma membranes. Signal from TGF-b type I receptor
acts with TGF-b signaling via p38 resulting in upregulation of col2a1 transcription. In
omplex in the col2a1 enhancer region. Arrows indicate pathways we examined in this
sed in this study are shown in respective pathways.
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gistically increased the col2a1 expression and the reporter activity
[Figs. 2(C) and 3(A)]. In other cells, it has already been shown that
the interaction between estrogen and the TGF-b signaling path-
ways occurs in multiple intracellular signaling steps to impact
downstream gene transcriptions33. Estrogen and tamoxifen can
increase TGF-b production by osteoblasts34. Thus, our results
coincided with previous reports showing a crosstalk between
estrogen and TGF-b signaling in mesenchymal lineage cells.
Results obtained from the reporter assays and various inhibitors
indicated that E2 transmits its signal through p38 MAPK in the
col2a1 transcription in ATDC5 cells [Fig. 3(A)]. It has already been
well established that the Sox9-dependent col2a1 enhancer activity
is regulated through MKK6 and p38 MAPK in PCs20. Thus, E2
appears to be one of the upstream signals of the col2a1 transcrip-
tional regulation through MKK6 and p38 MAPK. Because TGF-b1
causes p38 MAPK activation without Smad in mouse mammary
epithelial cells14, we speculate that the Smad-independent TGF-b
signaling elicits p38 MAPK activation in the E2 induced the col2a1
expression (see Fig. 6 for details). Future studies are needed to
clarify the complexity of such crosstalks.
Because GRIP1 is widely recognized as a transcriptional
coactivator of the nuclear receptors including ERa, we examined
the role of GRIP1 in the E2 induced col2a1 expression in ATDC5 cells.
As expected, the experiments using GRIP1 siRNA clearly showed
the involvement of GRIP1 in the E2 induced col2a1 expression
[Fig. 5(A)]. Moreover, GRIP1 siRNA inhibited the production of
sulfated GAGs in ATDC5 cells, implying a wider range of estrogen-
dependent transcriptional controls of extracellular matrix proteins
in chondrocytes.
Taken together, the results obtained in this study accord with
a notion that GRIP1-bound ERa induces the col2a1 gene expression
through an interaction with the TGF/MKK6 pathway. This study
sheds a light on the apparent controversies about the relationship
between the role of estrogen and cartilage degeneration in post-
menopausal women. A novel functional cooperation between
GRIP1/ERa and TGF/MKK6 signaling, shown in our study, may
therefore lead to a better understanding of transcriptional
networks and the development of a novel therapeutics approach
against postmenopausal cartilage degeneration in the future.
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